Malignancy grade-dependent expression of K+-channel subtypes in human prostate cancer. 2009

Susumu Ohya, and Kazunori Kimura, and Satomi Niwa, and Akitoshi Ohno, and Yoshiyuki Kojima, and Shoichi Sasaki, and Kenjiro Kohri, and Yuji Imaizumi
Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.

K(+) channels are key molecules in the progression of several cancer types and considered to be potential targets for cancer therapy. We examined the gene expressions of voltage-gated (K(v)), Ca(2+)-activated (K(Ca)), and two-pore domain (K(2P)) K(+)-channel subtypes in needle-biopsy samples of human prostate cancer (PCa) by real-time PCR and compared them with those in PCa epithelial cell lines. The expression of K(v)1.3, K(Ca)1.1, K(Ca)3.1, and K(2P)1 markedly increased in the PCa group with Gleason score of 5 - 6 (GS5-6) but significantly decreased in the GS8-9 group. This malignancy grade-dependent K(+)-channel expression pattern may provide a convenient marker to understand PCa progression level.

UI MeSH Term Description Entries
D008297 Male Males
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D015221 Potassium Channels Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits. Ion Channels, Potassium,Ion Channel, Potassium,Potassium Channel,Potassium Ion Channels,Channel, Potassium,Channel, Potassium Ion,Channels, Potassium,Channels, Potassium Ion,Potassium Ion Channel
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D017430 Prostate-Specific Antigen A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer. Kallikrein hK3,gamma-Seminoprotein,hK3 Kallikrein,Prostate Specific Antigen,Semenogelase,Seminin,Kallikrein, hK3,gamma Seminoprotein
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Susumu Ohya, and Kazunori Kimura, and Satomi Niwa, and Akitoshi Ohno, and Yoshiyuki Kojima, and Shoichi Sasaki, and Kenjiro Kohri, and Yuji Imaizumi
March 2013, Zhonghua nan ke xue = National journal of andrology,
Susumu Ohya, and Kazunori Kimura, and Satomi Niwa, and Akitoshi Ohno, and Yoshiyuki Kojima, and Shoichi Sasaki, and Kenjiro Kohri, and Yuji Imaizumi
October 2013, Journal of leukocyte biology,
Susumu Ohya, and Kazunori Kimura, and Satomi Niwa, and Akitoshi Ohno, and Yoshiyuki Kojima, and Shoichi Sasaki, and Kenjiro Kohri, and Yuji Imaizumi
March 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Susumu Ohya, and Kazunori Kimura, and Satomi Niwa, and Akitoshi Ohno, and Yoshiyuki Kojima, and Shoichi Sasaki, and Kenjiro Kohri, and Yuji Imaizumi
November 2012, Journal of clinical & experimental oncology,
Susumu Ohya, and Kazunori Kimura, and Satomi Niwa, and Akitoshi Ohno, and Yoshiyuki Kojima, and Shoichi Sasaki, and Kenjiro Kohri, and Yuji Imaizumi
January 2006, The Journal of membrane biology,
Susumu Ohya, and Kazunori Kimura, and Satomi Niwa, and Akitoshi Ohno, and Yoshiyuki Kojima, and Shoichi Sasaki, and Kenjiro Kohri, and Yuji Imaizumi
January 1986, Der Urologe. Ausg. A,
Susumu Ohya, and Kazunori Kimura, and Satomi Niwa, and Akitoshi Ohno, and Yoshiyuki Kojima, and Shoichi Sasaki, and Kenjiro Kohri, and Yuji Imaizumi
June 2001, Molecular pharmacology,
Susumu Ohya, and Kazunori Kimura, and Satomi Niwa, and Akitoshi Ohno, and Yoshiyuki Kojima, and Shoichi Sasaki, and Kenjiro Kohri, and Yuji Imaizumi
February 1999, British journal of cancer,
Susumu Ohya, and Kazunori Kimura, and Satomi Niwa, and Akitoshi Ohno, and Yoshiyuki Kojima, and Shoichi Sasaki, and Kenjiro Kohri, and Yuji Imaizumi
June 2001, The Journal of biological chemistry,
Susumu Ohya, and Kazunori Kimura, and Satomi Niwa, and Akitoshi Ohno, and Yoshiyuki Kojima, and Shoichi Sasaki, and Kenjiro Kohri, and Yuji Imaizumi
May 1992, FEBS letters,
Copied contents to your clipboard!